FrancophonIA/ELRC3.0 huggingface dataset:
English: Levetiracetam Actavis Group contains methyl parahydroxybenzoate, propyl parahydroxybenzoate, maltitol, propylene glycol and sodium.
Danish: Levetiracetam Actavis Group indeholder methylparahydroxybenzoat, propylparahydroxybenzoat, maltitol, propylenglycol og natrium
English: General dose: Levetiracetam Actavis Group is taken twice daily, in two equally divided doses, each individual dose being measured between 5 ml (500 mg) and 15 ml (1,500 mg).
Danish: Sædvanlig dosis: Levetiracetam Actavis Group tages to gange dagligt i to lige store doser, idet der til hver dosis afmåles mellem 5 ml (500 mg) og 15 ml (1.500 mg).
English: Dose in infants (1 month to less than 6 months):
Danish: Dosis til spædbørn (1 måned til under 6 måneder):
English: • suicide attempt and suicidal ideation, mental disorder, abnormal behaviour, hallucination, anger,
Danish: • selvmordsforsøg og selvmordstanker, mental ubalance, unormal adfærd, hallucinationer, vrede,
English: Infants should start the treatment with Levetiracetam Actavis Group 100 mg/ml oral solution.
Danish: Spædbørn bør starte behandlingen med Levetiracetam 100 mg/ml oral opløsning.
English: Sixty of these patients were treated with levetiracetam in placebo-controlled studies.
Danish: 60 af disse patienter blev behandlet med levetiracetam i placebokontrollerede studier.
English: Hypersensitivity to the active substance or other pyrrolidone derivatives or to any of the excipients listed in section 6.1.
Danish: Overfølsomhed over for det aktive stof eller andre pyrrolidonderivater eller over for et eller flere af hjælpestofferne anført i pkt.
English: After oral administration the bitter taste of levetiracetam may be experienced.
Danish: Den bitre smag af levetiracetam kan opleves efter oralt indtag.
English: In patients aged 1 month to less than 4 years, a total of 190 patients have been treated with levetiracetam in placebo-controlled and open label extension studies.
Danish: I alt 190 patienter i alderen 1 måned til under 4 år er blevet behandlet med levetiracetam i placebokontrollerede og åbne, forlængede studier.
English: Open the bottle and push the syringe adaptor firmly into the bottle neck (Figure 1).
Danish: Åben flasken og pres sprøjteadapteren ned over flaskehalsen (figur 1).
English: Following single oral dose administration (20 mg/kg) to epileptic children (6 to 12 years), the half-life of levetiracetam was 6.0 hours.
Danish: Efter indgivelse af en enkelt oral dosis (20 mg/kg) til børn (6-12 år) med epilepsi, var halveringstiden for levetiracetam 6,0 timer.
English: Levetiracetam 2,000 mg daily did not influence the pharmacokinetics of digoxin and warfarin; prothrombin times were not modified.
Danish: Levetiracetam 2.000 mg daglig påvirkede ikke farmakokinetik af digoxin og warfarin;
English: If you get any side effects talk to your doctor or pharmacist.
Danish: Hvis De oplever bivirkninger, bør De tale med Deres læge, sygeplejerske eller apoteket.
English: The oral solution is the preferred formulation for use in infants and children under the age of 6 years.
Danish: Den orale opløsning foretrækkes til spædbørn og børn under 6 år.
English: In order to ensure the accuracy of the dosing, this presentation should be prescribed for infants and young children aged from 6 months to less than 4 years.
Danish: For at sikre nøjagtig dosering bør denne pakningsstørrelse ordineres til spædbørn og småbørn i alderen fra 6 måneder til under 4 år.
English: Each ml contains 1.50 mg of methyl parahydroxybenzoate (E218), 0.15 mg of propyl parahydroxybenzoate (E216), 290 mg of maltitol liquid (E965), 3,26 mg propylene glycol (E 1520) and 0.25 mg of sodium.
Danish: Hver ml indeholder 1,50 mg methylparahydroxybenzoat (E218), 0,15 mg propylparahydroxybenzoat (E216), 290 mg flydende maltitol (E965), 3,26 mg propylenglycol (E1520) og 0,25 mg natrium.
English: Efficacy of levetiracetam as monotherapy was established in a double-blind, parallel group, noninferiority comparison to carbamazepine controlled release (CR) in 576 patients 16 years of age or older with newly or recently diagnosed epilepsy.
Danish: Effekten af levetiracetam som monoterapi behandling blev påvist i et dobbeltblindt, ækvivalensstudie med parallelle grupper med carbamazepin depottabletter (CR) hos 576 patienter over 16 år med ny eller nyligt diagnosticeret epilepsi.
English: Very common: may affect more than 1 in 10 people
Danish: Meget almindelig: kan forekomme hos mere end 1 ud af 10 personer
English: Contents of the pack and other information What Levetiracetam Actavis Group contains
Danish: Pakningsstørrelser og yderligere oplysninger Levetiracetam Actavis Group indeholder:
English: The safety and efficacy of levetiracetam in children and adolescents below 16 years as monotherapy treatment have not been established.
Danish: Levetiracetams sikkerhed og virkning som monoterapibehandling hos børn og unge under 16 år er ikke klarlagt.
English: The NOAEL (No Observed Adverse Effect Level) was 3,600 mg/kg/day for pregnant female rats (x 12 the MRHD on a mg/m2 basis) and 1,200 mg/kg/day for fetuses.
Danish: NOAEL (No Observed Adverse Effect Level) var 3.600 mg/kg/dag for gravide hunrotter (12 x MRHD (Maximum Recommended Human Dose) på basis af mg/m2) og 1.200 mg/kg/dag for fostre.
English: 72.2% of the levetiracetam treated patients and 45.2% of the patients on placebo had a 50% or greater decrease in the frequency of PGTC seizures per week.
Danish: 72,2 % af de patienter, som blev behandlet med levetiracetam, og 45,2 % af de patienter, som fik placebo, havde 50 % eller større reduktion i frekvensen af PGTC anfald pr. uge.
English: • limp or difficulty walking.
Danish: • halten eller gangbesvær.
English: Dose in adults and adolescents from 16 years of age:
Danish: Dosis til voksne og unge fra 16 år:
English: • injury.
Danish: • skader ved uheld.
English: 1,500 mg twice daily (1) Children 25 kg or less should preferably start the treatment with Levetiracetam Actavis Group
Danish: 1.500 mg to gange daglig (1) Børn på 25 kg og derunder bør starte behandlingen med Levetiracetam Actavis Group 100 mg/ml oral opløsning.
English: Depression, hostility/ aggression, anxiety, insomnia, nervousness/irritability
Danish: Depression, fjendtlighed/ aggression, angst, insomni, nervøsitet/ irritabilitet
English: Antiepileptic medicinal products
Danish: Antiepileptika
English: Levetiracetam Actavis Group oral solution contains propylene glycol (E1520).
Danish: Levetiracetam Actavis Group oral opløsning indeholder propylenglycol (E1520).
English: The possible side effects of an overdose of Levetiracetam Actavis Group are sleepiness, agitation, aggression, decrease of alertness, inhibition of breathing and coma.
Danish: Bivirkningerne af en overdosis af Levetiracetam Actavis Group er søvnighed, uro, aggressiv adfærd, nedsat årvågenhed, vejrtrækningsbesvær og koma.
English: Levetiracetam Actavis Group oral solution also contains maltitol.
Danish: Levetiracetam Actavis Group indeholder også maltitol.
English: In order to ensure the accuracy of the dosing, this presentation should be prescribed for infants aged 1 month to less than 6 months.
Danish: For at sikre nøjagtig dosering bør denne pakningsstørrelse ordineres til spædbørn i alderen 1 måned til under 6 måneder.
English: Four embryo-foetal development studies were performed in rabbits covering doses of 200, 600, 800, 1,200 and 1,800 mg/kg/day.
Danish: Der blev udført fire embryo-føtale udviklingsstudier med doser på 200, 600, 800, 1.200 og 1.800 mg/kg/dag i kaniner.
English: Patients with rare hereditary problems of fructose intolerance should not take this medicine.
Danish: Bør ikke anvendes til patienter med hereditær fructoseintolerans.
English: Dosing adjustment for adult and adolescents patients weighing more than 50 kg with impaired renal function:
Danish: Dosisjustering for voksne og unge patienter, der vejer mere end 50 kg, med nedsat nyrefunktion Group
English: Steady-state is achieved after two days of a twice daily administration schedule.
Danish: Stabilt plasmaniveau (steady state) opnås indenfor 2 dage med dosering 2 gange dagligt.
English: Wash the syringe with water after use and close the bottle with the plastic screw cap (Figure 10).
Danish: Vask sprøjten med vand efter brug og luk flasken med plastikskruelåget (figur 10).
English: For children aged 6 months to less than 4 years
Danish: Til børn fra 6 måneder til under 4 år
English: • uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity);
Danish: • ukontrollerede muskelspasmer med indvirkning på hovedet, kroppen samt arme og ben; vanskelighed med at kontrollere kroppens bevægelser, ufrivillige bevægelser;
English: Dose changes should not exceed increases or decreases of 7 mg/kg twice daily every two weeks.
Danish: Dosisændring bør ikke overskride en dosisøgning eller -reduktion på mere end 7 mg/kg to gange dagligt hver anden uge.
English: What you need to know before you take Levetiracetam Actavis Group Do not take Levetiracetam Actavis Group
Danish: Det skal du vide, før du begynder at tage Levetiracetam Actavis Group Tag ikke Levetiracetam Actavis Group
English: Abdominal pain, diarrhoea, dyspepsia, vomiting, nausea
Danish: Abdominalsmerter, diarré, dyspepsi, opkastning, kvalme
English: Instruction for use: Instruction for use for 10 ml syringes
Danish: Brugsanvisning til 10 ml sprøjter
English: Dose changes should not exceed increases or decreases of 10 mg/kg twice daily every two weeks.
Danish: Dosisændring bør ikke overskride en dosisøgning eller -reduktion på mere end 10 mg/kg to gange dagligt hver anden uge.
English: • somnolence (sleepiness), headache.
Danish: • døsighed, hovedpine.
English: The maximum dose is 1,500 mg twice daily.
Danish: Den maksimale dosis er 1.500 mg to gange daglig.
English: Maltitol liquid (E965) Acesulfame potassium (E950) Grape flavour (contains propylene glycol) Purified water
Danish: Maltitol, flydende (E 965) Acesulfamkalium (E 950) Drueessens (indeholder Propylenglycol) Vand, renset
English: The NOAEL was ≥ 1,800 mg/kg/day for the F0 females, and for the survival, growth and development of the F1 offspring up to weaning (x 6 the MRHD on a mg/m2 basis).
Danish: NOAEL var ≥ 1.800 mg/kg/dag for F0-hunnerne samt for overlevelse, vækst og udvikling af F1-afkom indtil ophør af diegivning (6 x MRHD på basis af mg/m2).
English: • hair loss, eczema, pruritus;
Danish: • hårtab, eksem, kløe;
English: Two embryo-foetal development (EFD) studies were performed in rats at 400, 1,200 and 3,600 mg/kg/day.
Danish: Der blev udført to embryo-føtale udviklingsstudier med 400, 1.200 og 3.600 mg/kg/dag i rotter.
English: Levetiracetam has been given to you by your doctor to reduce the number of fits.
Danish: Du har fået levetiracetam af din læge for at nedbringe antallet af anfald.
English: Talk to your doctor before taking Levetiracetam Actavis Group
Danish: Kontakt lægen, før du tager Levetiracetam Actavis Group
English: • severe allergic reactions (DRESS, anaphylactic reaction [severe and important allergic reaction],
Danish: • alvorlige allergiske reaktioner (DRESS, anafylaktisk reaktion (alvorlig og vigtig allergisk reaktion), Quinckes ødem (hævelse af ansigt, læber, tunge og svælg));
English: The other ingredients are: sodium citrate, citric acid monohydrate, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), ammonium glycyrrhizate, glycerin, glycerol (E422), maltitol liquid (E965), acesulfame potassium (E950), grape flavour (contains propylene glycol), purified water.
Danish: De øvrige indholdsstoffer er: Natriumcitrat, citronsyremonohydrat, methylparahydroxybenzoat (E218), propylparahydroxybenzoat (E216), ammoniumglycyrrhizat, glycerin, glycerol (E422), flydende maltitol (E965), aceculfamkalium (E950), drueessens, propylenglycol, renset vand.
English: Dose in children and adolescents 50 kg or more is the same as in adults.
Danish: (2) Dosis til børn og unge over 50 kg er den samme som til voksne.
English: 44.6% of the levetiracetam treated patients and 19.6% of the patients on placebo had a 50% or greater reduction from baseline in the partial onset seizure frequency per week.
Danish: 44,6 % af de patienter, som fik levetiracetam og 19,6 % af de patienter, som fik placebo, havde 50 % eller større reduktion i frekvensen af partielle anfald pr. uge, i forhold til baseline.
English: (4) Following dialysis, a 3.5 to 7 mg/kg (0.035 to 0.07 ml/kg) supplemental dose is recommended.
Danish: (4) Efter dialyse anbefales 3,5 til 7 mg/kg (0,035 til 0,07 ml/kg) som supplerende dosis.
English: Wash the syringe with water after use and close the bottle with the plastic screw cap (Figure 4).
Danish: Vask sprøjten med vand efter brug og luk flasken med plastikskruelåget (figur 4).
English: Levetiracetam elimination is correlated to creatinine clearance.
Danish: Elimination af levetiracetam er korreleret til kreatininclearance.
English: Rhabdomyolysis and blood creatine phosphokinase increased*
Danish: Rabdomyolyse og forhøjet indhold af kreatinkinase i blodet*
English: • abdominal pain, diarrhoea, dyspepsia (indigestion), vomiting, nausea;
Danish: • mavesmerter, diarré, dyspepsi (fordøjelsesbesvær), opkastning, kvalme;
English: confusion, panic attack, emotional instability/mood swings, agitation;
Danish: forvirring, panikanfald, følelsesmæssig ustabilitet/humørsvingninger, rastløs uro;
English: (3) A 15 mg/kg (0.15 ml/kg) loading dose is recommended on the first day of treatment with levetiracetam.
Danish: (3) En 15 mg/kg (0,15 ml/kg) støddosis anbefales på den første behandlingsdag med levetiracetam.
English: Turn the bottle upside down with the syringe still in place (Figure 4).
Danish: Vend flasken på hovedet med sprøjten stadig siddende fast (figur 4).
English: Levetiracetam Actavis Group is not indicated in children and adolescents below 16 years on its own (monotherapy).
Danish: Levetiracetam Actavis Group, som eneste lægemiddel (monoterapi), er ikke indiceret til børn og unge under 16 år.
English: Suicide attempt, suicidal ideation, psychotic disorder, abnormal behaviour, hallucination, anger, confusional state , panic attack, affect lability/mood swings, agitation
Danish: Selvmordsforsøg selvmordstanker, psykose, unormal adfærd, hallucinationer, vrede, konfusion, panikanfald, affektlabilitet/ humørsvingninger, agitation
English: With continued long-term treatment, 47.4% of the patients were free of tonic-clonic seizures for at least 6 months and 31.5% were free of tonic-clonic seizures for at least 1 year.
Danish: Ved fortsat langtidsbehandling var 47,4 % af patienterne fri for tonisk-kloniske anfald i mindst 6 måneder og 31,5 % var fri for tonisk-kloniske anfald i mindst 1 år.
English: 500 to 1,000 mg once daily (2)
Danish: 500 til 1,000 mg en gang dagligt (2)
English: (2) A 10.5 mg/kg (0.105 ml/kg) loading dose is recommended on the first day of treatment with levetiracetam.
Danish: (2) En 10,5 mg/kg (0,105 ml/kg) støddosis anbefales på den første behandlingsdag med levetiracetam.
English: Levetiracetam Actavis Group oral solution should be used for doses under 250 mg, for doses not multiple of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets.
Danish: som ikke er delelig med 250 mg, når anbefalet dosis ikke kan opnås ved at tage flere tabletter og til patienter, der ikke er i stand til at sluge tabletter.
English: Depending upon the clinical response and tolerability, the dose can be increased up to 30 mg/kg twice daily.
Danish: Afhængigt af klinisk respons og tolerabilitet kan dosis øges til højst 30 mg/kg to gange dagligt.
English: Dosing adjustment for infants, children and adolescent patients weighing less than 50 kg with impaired renal function:
Danish: Dosisjustering for spædbørn, børn og unge, der vejer mindre end 50 kg, med nedsat nyrefunktion Gruppe
English: 300 ml oral solution with a 10 ml oral syringe.
Danish: 300 ml oral opløsning med en 10 ml sprøjte.
English: General dose: Levetiracetam Actavis Group is taken twice daily, in two equally divided doses, each individual dose being measured between 0.1 ml (10 mg) and 0.3 ml (30 mg), per kg bodyweight of the child. (see table below for dose examples).
Danish: Sædvanlig dosis: Levetiracetam Actavis Group gives to gange dagligt i to lige store doser, idet der til hver dosis afmåles mellem 0,1 ml (10 mg) og 0,3 ml (30 mg) pr. kg af barnets legemsvægt (se tabellen nedenfor, der indeholder eksempler på dosis).
English: Depending upon the clinical response and tolerability, the dose can be increased up to 21 mg/kg twice daily.
Danish: Afhængigt af klinisk respons og tolerabilitet kan dosis øges til højst 21 mg/kg to gange dagligt.
English: • amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia
Danish: • amnesi (hukommelsestab), hukommelsessvækkelse (glemsomhed), koordinationsbesvær,
English: As with all antiepileptic medicines, sudden discontinuation of levetiracetam should be avoided as this may lead to breakthrough seizures that could have serious consequences for the woman and the unborn child. Monotherapy should be preferred whenever possible because therapy with multiple antiepileptic medicines AEDs could be associated with a higher risk of congenital malformations than monotherapy, depending on the associated antiepileptics.
Danish: Hvis det er muligt så foretrækkes monoterapi, da behandling med flere antiepileptika (AED'er) kunne være forbundet med højere risiko for medfødte misdannelser end behandling med monoterapi, afhængigt af de pågældende antiepileptika.
English: Depending upon the clinical response and tolerability, the daily dose can be increased up to 1,500 mg twice daily.
Danish: Afhængig af klinisk effekt og tolerabilitet kan den daglige dosis øges til 1.500 mg to gange daglig.
English: Methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) Levetiracetam Actavis Group 100 mg/ml oral solution contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed).
Danish: Methylparahydroxybenzoat (E218) og propylparahydroxybenzoat (E216) Levetiracetam Actavis Group 100 mg/ml oral opløsning indeholder methylparahydroxybenzoat (E 218) og propylparahydroxybenzoat (E 216), som kan medføre allergiske reaktioner (muligvis forsinket).
English: Rare: may affect up to 1 in 1,000 people
Danish: Sjælden: kan forekomme hos op til 1 ud af 1000 personer
English: In paediatric patients (1 month to less than 4 years of age), levetiracetam efficacy was established in a double-blind, placebo-controlled study, which included 116 patients and had a treatment duration of 5 days.
Danish: Effekten af levetiracetam hos pædiatriske patienter (1 måned til under 4 år) blev påvist i et dobbelblindt, placebokontrolleret forsøg med 116 patienter og en behandlingsvarighed på 5 dage.
English: In paediatric patients (4 to 16 years of age), levetiracetam efficacy was established in a double-blind, placebo-controlled study, which included 198 patients and had a treatment duration of 14 weeks.
Danish: Effekten af levetiracetam hos pædiatriske patienter (4-16 år) blev påvist i et dobbeltblindt placebokontrolleret forsøg med 198 patienter og en behandlingsvarighed på 14 uger.
English: No adverse reactions on male or female fertility or reproduction performance were observed in rats at doses up to 1,800 mg/kg/day (x 6 the MRHD on a mg/m2 or exposure basis) in parents and F1 generation.
Danish: Der blev ikke observeret bivirkninger mht. mandlig eller kvindelig fertilitet eller andre reproduktionsparametre hos rotter ved doser på op til 1.800 mg/kg/dag (6 x MRHD på basis af mg/m2) i forældre og F1-afkom.
English: Dose changes can be made in 500 mg twice daily increases or decreases every two to four weeks.
Danish: Dosisændring kan gennemføres med en dosisøgning eller -reduktion på 500 mg to gange daglig hver anden til fjerde uge.
English: The CLcr in ml/min may be estimated from serum creatinine (mg/dl) determination, for adults and adolescents weighing 50 kg or more, the following formula:
Danish: Hos voksne og unge, som vejer over 50 kg, kan CLcr i ml/min beregnes ud fra serumkreatinin (mg/dl) ved at anvende følgende formel:
English: End-stage renal disease patients undergoing dialysis
Danish: Patienter i slutstadiet af nyresygdom, som får dialyse
English: With continued long-term treatment, 28.6% of the patients were free of myoclonic seizures for at least 6 months and 21.0% were free of myoclonic seizures for at least 1 year.
Danish: Ved fortsat langtidsbehandling var 28,6 % af patienterne fri for myoklone anfald i mindst 6 måneder, og 21,0 % var fri for myoklone anfald i mindst 1 år.
English: For children 6 months to 4 years, measure the appropriate dosage using the 3 ml syringe included in the package.
Danish: Til børn fra 6 måneder til 4 år afmåles den korrekte dosis ved hjælp af 3 ml-sprøjten, som er vedlagt pakningen.
English: The CLcr in ml/min/1.73 m2 may be estimated from serum creatinine (mg/dl) determination using, for young adolescents, children and infants, using the following formula (Schwartz formula):
Danish: CLcr i ml/min/1,73 m2 kan, hos ganske unge, børn og spædbørn, beregnes ud fra serumkreatinin
English: In this study, levetiracetam, dose was 3,000 mg/day given in 2 divided doses.
Danish: I dette forsøg var dosis af levetiracetam 3.000 mg/dag fordelt på 2 doser.
English: (5) Following dialysis, a 5 to 10 mg/kg (0.05 to 0.10 ml/kg) supplemental dose is recommended.
Danish: (5) Efter dialyse anbefales 5 til 10 mg/kg (0,05 til 0,10 ml/kg) som supplerende dosis.
English: Pull the syringe by the dosing body out of the bottle (Figure 2).
Danish: Træk sprøjten ud af flasken ved at holde fast på doseringsdelen (figur 2).
English: Use the 10 ml syringe included in the package.
Danish: Anvend 10 ml sprøjten inkluderet i pakken.
English: The 300 ml glass bottle of Levetiracetam Actavis Group (for children aged 4 years and above, adolescents and adults) is packed in a cardboard box containing a 10 ml oral syringe (graduated every 0.25 ml).
Danish: Glasflasken med 300 ml Levetiracetam Actavis Group (til børn fra 4 år og opefter, unge og voksne) er pakket i en æske, der indeholder en 10 ml oral doseringssprøjte (med en målestreg for hver 0,25 ml).
English: Levetiracetam Actavis Group 100 mg/ml oral solution is a clear, faint yellowish-brown solution.
Danish: Levetiracetam Actavis Group 100 mg/ml oral opløsning er en klar, svagt gul-brun opløsning.
English: Dose in children 6 months and older:
Danish: Dosis til børn på 6 måneder og derover:
English: In children and adolescents aged 4 to 16 years, vomiting (very common, 11.2%), agitation (common, 3.4%), mood swings (common, 2.1%), affect lability (common, 1.7%), aggression (common, 8.2%), abnormal behaviour (common, 5.6%), and lethargy (common, 3.9%) were reported more frequently than in other age ranges or in the overall safety profile.
Danish: affektlabilitet (almindelig, 1,7 %), aggression (almindelig, 8,2 %), unormal adfærd (almindelig, 5,6 %) og letargi (almindelig, 3,9 %) end i andre aldersgrupper eller i den samlede sikkerhedsprofil.
English: Use the 10 ml oral syringe included in the package
Danish: Anvend den orale 10 ml sprøjte inkluderet i pakningen
English: Neonatal and juvenile animal studies in rats and dogs demonstrated that there were no adverse effects seen in any of the standard developmental or maturation endpoints at doses up to 1,800 mg/kg/day (x 6- 17 the MRHD on a mg/m2 basis).
Danish: Neonatale og juvenile dyrestudier med rotter og hunde demonstrerede, at der med doser op til 1.800 mg/kg/dag (6-17 x MRHD på basis af mg/m2) ikke var uønskede virkninger på standardudvikling og modningsmålepunkter.
English: Levetiracetam Actavis Group oral solution includes methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed).
Danish: Levetiracetam Actavis Group 100 mg/ml oral opløsning indeholder methylparahydroxybenzoat (E 218) og propylparahydroxybenzoat (E 216), som kan medføre allergiske reaktioner (muligvis forsinket).
English: Starting dose: 0.07 ml/kg twice daily Maximum dose: 0.21 ml/kg twice daily
Danish: Initial dosis: 0,07 ml/kg to gange dagligt Maksimal dosis: 0,21 ml/kg to gange dagligt